JPWO2020177818A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020177818A5 JPWO2020177818A5 JP2021547493A JP2021547493A JPWO2020177818A5 JP WO2020177818 A5 JPWO2020177818 A5 JP WO2020177818A5 JP 2021547493 A JP2021547493 A JP 2021547493A JP 2021547493 A JP2021547493 A JP 2021547493A JP WO2020177818 A5 JPWO2020177818 A5 JP WO2020177818A5
- Authority
- JP
- Japan
- Prior art keywords
- chewing gum
- gum composition
- composition according
- compressed chewing
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940112822 chewing gum Drugs 0.000 claims 32
- 235000015218 chewing gum Nutrition 0.000 claims 32
- 239000000203 mixture Substances 0.000 claims 29
- 229930003827 cannabinoid Natural products 0.000 claims 12
- 239000003557 cannabinoid Substances 0.000 claims 12
- 229940065144 cannabinoids Drugs 0.000 claims 11
- 239000002245 particle Substances 0.000 claims 10
- 229920001971 elastomer Polymers 0.000 claims 5
- 239000000806 elastomer Substances 0.000 claims 5
- 239000004014 plasticizer Substances 0.000 claims 4
- 229920002689 polyvinyl acetate Polymers 0.000 claims 4
- 239000011118 polyvinyl acetate Substances 0.000 claims 4
- 239000004615 ingredient Substances 0.000 claims 3
- ZROLHBHDLIHEMS-HUUCEWRRSA-N (6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCC)=CC(O)=C3[C@@H]21 ZROLHBHDLIHEMS-HUUCEWRRSA-N 0.000 claims 2
- UCONUSSAWGCZMV-HZPDHXFCSA-N Delta(9)-tetrahydrocannabinolic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C(O)=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-N 0.000 claims 2
- ZROLHBHDLIHEMS-UHFFFAOYSA-N Delta9 tetrahydrocannabivarin Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCC)=CC(O)=C3C21 ZROLHBHDLIHEMS-UHFFFAOYSA-N 0.000 claims 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims 2
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 claims 2
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 2
- 229920005601 base polymer Polymers 0.000 claims 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 2
- 229950011318 cannabidiol Drugs 0.000 claims 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 2
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 2
- 229960004242 dronabinol Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims 1
- REOZWEGFPHTFEI-JKSUJKDBSA-N Cannabidivarin Chemical compound OC1=CC(CCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 REOZWEGFPHTFEI-JKSUJKDBSA-N 0.000 claims 1
- 208000027205 Congenital disease Diseases 0.000 claims 1
- 208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 206010048685 Oral infection Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 230000004596 appetite loss Effects 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 208000019017 loss of appetite Diseases 0.000 claims 1
- 235000021266 loss of appetite Nutrition 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000025 natural resin Substances 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 208000020016 psychiatric disease Diseases 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
Claims (20)
i)第1の粒子集団が、1種又は複数種のポリ酢酸ビニルエラストマー可塑剤を含む非水溶性ガムベースを含み、ガムベースポリマーは、5質量%未満のラウリン酸ビニル-酢酸ビニルコポリマーを含み、
ii)第2の粒子集団が水溶性チューインガム成分を含み、第2の粒子集団が非水溶性ガムベースを含まず、
複数種の粒子内に位置する水溶性チューインガム成分及びガムベースポリマーを含む非水溶性ガムベースを含み、
0.1~200mgの量で1種又は複数種のカンナビノイドを含む、打錠チューインガム組成物。 A compressed chewing gum composition for oral administration of cannabinoids comprising:
i) the first particle population comprises a water-insoluble gum base comprising one or more polyvinyl acetate elastomer plasticizers, the gum base polymer comprising less than 5% by weight of a vinyl laurate-vinyl acetate copolymer;
ii) the second population of particles comprises a water-soluble chewing gum ingredient and the second population of particles does not comprise a water-insoluble gum base;
a water-insoluble gum base comprising a plurality of water-soluble chewing gum ingredients located in particles and a gum base polymer ;
A compressed chewing gum composition comprising one or more cannabinoids in an amount of 0.1-200 mg .
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/289,714 | 2019-03-01 | ||
US16/289,714 US10933017B2 (en) | 2019-03-01 | 2019-03-01 | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
CA3035409A CA3035409C (en) | 2019-03-01 | 2019-03-01 | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
CA3,035,409 | 2019-03-01 | ||
PCT/DK2019/050307 WO2020177818A1 (en) | 2019-03-01 | 2019-10-10 | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2022521896A JP2022521896A (en) | 2022-04-13 |
JPWO2020177818A5 true JPWO2020177818A5 (en) | 2022-10-19 |
JP7531500B2 JP7531500B2 (en) | 2024-08-09 |
Family
ID=68617968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021547493A Active JP7531500B2 (en) | 2019-03-01 | 2019-10-10 | Tableted cannabinoid chewing gum containing a polyvinyl acetate elastomer plasticizer |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3876916B1 (en) |
JP (1) | JP7531500B2 (en) |
CN (1) | CN113329743B (en) |
AU (1) | AU2019432305B2 (en) |
DK (1) | DK3876916T3 (en) |
WO (1) | WO2020177818A1 (en) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5397580A (en) * | 1993-10-22 | 1995-03-14 | Wm. Wrigley Jr. Company | Continuous gum base manufacture using sequential mixers |
DE60217731T2 (en) * | 2002-07-02 | 2007-10-18 | Gumlink A/S | COMPRESSED RESIN KABELET |
US6986907B2 (en) | 2003-07-28 | 2006-01-17 | Wm. Wrigley Jr. Company | Chewing gum base and chewing gum compositions |
WO2009007769A1 (en) * | 2007-07-06 | 2009-01-15 | Gumlink A/S | Multi-modular chewing gum tablet |
EP2229157B1 (en) * | 2007-12-20 | 2016-08-10 | Fertin Pharma A/S | Compressed chewing gum tablet |
PT2280687T (en) | 2008-03-26 | 2019-06-04 | Stichting Sanammad | Chewing gum compositions comprising cannabinoids |
EP3359142B1 (en) * | 2015-10-07 | 2020-12-09 | NordicCan A/S | Medical chewing gum comprising cannabinoid |
US10842786B2 (en) * | 2016-04-27 | 2020-11-24 | Apirx Pharmaceutical Usa, Llc | Chewing gum composition comprising cannabinoids and nicotine |
US11529329B2 (en) * | 2016-05-27 | 2022-12-20 | Nordiccan A/S | Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin |
JP6908717B2 (en) * | 2016-11-18 | 2021-07-28 | フェルティン ファルマ アー/エス | Oral delivery vehicle |
CA3031530C (en) * | 2019-01-25 | 2021-03-23 | Medcan Pharma A/S | Cannabinoid chewing gum with sugar alcohols |
-
2019
- 2019-10-10 AU AU2019432305A patent/AU2019432305B2/en active Active
- 2019-10-10 DK DK19805886.9T patent/DK3876916T3/en active
- 2019-10-10 EP EP19805886.9A patent/EP3876916B1/en active Active
- 2019-10-10 CN CN201980090207.3A patent/CN113329743B/en active Active
- 2019-10-10 JP JP2021547493A patent/JP7531500B2/en active Active
- 2019-10-10 WO PCT/DK2019/050307 patent/WO2020177818A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11654111B2 (en) | Oral solid cannabinoid formulations, methods for producing and using thereof | |
EP3448521B1 (en) | Chewing gum composition comprising cannabinoids and nicotine | |
US11590230B2 (en) | Compositions of therapeutic substances, methods and uses thereof | |
US11712430B2 (en) | Formulated cannabis oil powder by nanoemulsification, methods of producing and uses thereof | |
WO2018165740A1 (en) | Modified release multi-layer tablet cannabinoid formulations | |
WO2009082459A2 (en) | Anti-aging composition containing resveratrol and method of administration | |
US20060189543A1 (en) | Compositions and methods for the treatment of leukemia | |
Jayusman et al. | Therapeutic potential of polyphenol and nanoparticles mediated delivery in periodontal inflammation: A review of current trends and future perspectives | |
US11717494B2 (en) | Oral solid cannabinoid oil composition for treating gastrointestinal disorders | |
CN104379138B (en) | Acamprosate formulations, methods of use thereof, and combinations comprising acamprosate formulations | |
WO2006097660A2 (en) | Use of an onion extract for making a composition to control weight gain | |
JPWO2020177818A5 (en) | ||
CN106822097A (en) | A kind of pharmaceutical composition containing orlistat for losing weight | |
JPWO2020177819A5 (en) | ||
JPWO2020035850A5 (en) | ||
EP4058002A1 (en) | Chewing gum containing synergistic medicinal compounds | |
JP2022553653A (en) | Controlled release formulation of highly lipophilic physiologically active substance | |
WO2007103528A2 (en) | Compressible resilient granules and formulations prepared therefrom | |
CN113423279A (en) | Tabletted cannabinoid chewing gum with layered structure | |
CN109432082B (en) | Pharmaceutical composition for preventing and treating chemical liver injury | |
EP4119124A1 (en) | Microemulsion containing orally disintegrating film compositions with adjustable physical and rheological properties | |
US20240139100A1 (en) | Transmucosal delivery of tocotrienols | |
CN113329743B (en) | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizer | |
JPWO2020151791A5 (en) | ||
WO2022148672A1 (en) | Oral solid cannabinoid oil composition for treating central nervous system disorders |